Availability and reimbursement of biological products for severe asthma in Bulgaria

Objectives: This study aims to analyze the reimbursement and cost of biological therapy for severe asthma in Bulgaria during 2014–2019 from the perspective of the National Health Insurance Fund. Methods: It is a retrospective, Marco-costing, top-down study of the expenditures for biological products...

Full description

Bibliographic Details
Main Authors: Petya Milushewa, Miglena Doneva, Guenka Petrova
Format: Article
Language:English
Published: SAGE Publishing 2020-08-01
Series:SAGE Open Medicine
Online Access:https://doi.org/10.1177/2050312120951067